The 2013 Canadian hypertension education program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension

Canadian Journal of Cardiology

Volumn 29, Issue 5, 2013, Pages 528-542

  Hackam, Daniel G ^a   Quinn, Robert R ^b   Ravani, Pietro ^b   Rabi, Doreen M ^b   Dasgupta, Kaberi ^c   Daskalopoulou, Stella S ^c   Khan, Nadia A ^d   Herman, Robert J ^b   Bacon, Simon L ^e   Cloutier, Lyne ^f   Dawes, Martin ^d   Rabkin, Simon W ^d   Gilbert, Richard E ^g   Ruzicka, Marcel ^h   McKay, Donald W ⁱ   Campbell, Tavis S ^j   Grover, Steven ^k   Honos, George ^l   Schiffrin, Ernesto L ^m   Bolli, Peter ⁿ   Wilson, Thomas W ^o   Feldman, Ross D ^a   Lindsay, Patrice ^p   Hill, Michael D ^q   Gelfer, Mark ^d   Burns, Kevin D ^d   Vallée, Michel ^r   Prasad, G V Ramesh ^p   Lebel, Marcel ^s   McLean, Donna ^t   Arnold, J Malcolm O ^a   Moe, Gordon W ^g   Howlett, Jonathan G ^j   Boulanger, Jean Martin ^u   Larochelle, Pierre ^v   Leiter, Lawrence A ^w   Jones, Charlotte ^d   Ogilvie, Richard I ^x   Woo, Vincent ^y   Kaczorowski, Janusz ^l   Trudeau, Luc ^z   Petrella, Robert J ^a   Milot, Alain ^s   Stone, James A ^j   Drouin, Denis ^s   Lavoie, Kim L ^aa   Lamarre Cliche, Maxime ^v   Godwin, Marshall ⁱ   Tremblay, Guy ^ab   Hamet, Pavel ^l   Fodor, George ^ac   Carruthers, S George ^ad   Pylypchuk, George B ^o   Burgess, Ellen ^b   Lewanczuk, Richard ^t   Dresser, George K ^ae   Penner, S Brian ^y   Hegele, Robert A ^a   McFarlane, Philip A ^g   Sharma, Mukul ^af   Reid, Debra J ^ag   Tobe, Sheldon W ^p   Poirier, Luc ^ab   Padwal, Raj S ^t   more..

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e Gina Cody School of Engineering and Computer Science   (Canada)

^f UNIVERSITÉ DU QUÉBEC À TROIS RIVIÈRES   (Canada)

^g ST MICHAEL'S HOSPITAL   (Canada)

^h OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

ⁱ MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^j UNIVERSITY OF CALGARY   (Canada)

^k MONTREAL GENERAL HOSPITAL   (Canada)

^l UNIVERSITÉ DE MONTRÉAL   (Canada)

^m MCGILL UNIVERSITY   (Canada)

ⁿ Ambulatory Internal Medicine Teaching Clinic   (Canada)

^o UNIVERSITY OF SASKATCHEWAN   (Canada)

^p UNIVERSITY OF TORONTO   (Canada)

^q UNIVERSITY OF CALGARY   (Canada)

^r MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

^s UNIVERSITÉ LAVAL   (Canada)

^t UNIVERSITY OF ALBERTA   (Canada)

^u UNIVERSITÉ DE SHERBROOKE   (Canada)

^v CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^w ST MICHAEL'S HOSPITAL   (Canada)

^x UNIVERSITY HEALTH NETWORK   (Canada)

^y UNIVERSITY OF MANITOBA   (Canada)

^z MCGILL UNIVERSITY   (Canada)

^aa UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

^ab LAVAL UNIVERSITY   (Canada)

^ac UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^ad CHU Québec Hôpital St Sacrement ^*

^ae WESTERN UNIVERSITY   (Canada)

^af Canadian Stroke Network   (Canada)

^ag DEPARTMENT OF NATIONAL DEFENCE   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE ANTAGONIST; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INDAPAMIDE; LOOP DIURETIC AGENT; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PERINDOPRIL; THIAZIDE DIURETIC AGENT; TRIACYLGLYCEROL;

ABDOMINAL PRESSURE; ALCOHOL CONSUMPTION; AMBULATORY MONITORING; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD CHEMISTRY; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; BORDERLINE HYPERTENSION; BRAIN ISCHEMIA; CALCIUM INTAKE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CORONARY ARTERY DISEASE; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DOPPLER ECHOGRAPHY; ECHOCARDIOGRAPHY; FIBRINOLYTIC THERAPY; FOLLOW UP; HEALTH BEHAVIOR; HEALTH EDUCATION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HOME MONITORING; HUMAN; HYPERALDOSTERONISM; HYPERTENSION; HYPOKALEMIA; LABORATORY TEST; MAGNETIC RESONANCE ANGIOGRAPHY; MONOTHERAPY; PATIENT COMPLIANCE; PHEOCHROMOCYTOMA; PHYSICAL EXAMINATION; PLASMA RENIN ACTIVITY; POTASSIUM INTAKE; PRIMARY PREVENTION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RELAXATION TRAINING; RENOVASCULAR HYPERTENSION; RESISTANCE TRAINING; RISK ASSESSMENT; STABLE ANGINA PECTORIS; STRESS MANAGEMENT; SUSTAINED DRUG RELEASE; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE; SYSTOLIC HYPERTENSION; URINALYSIS; URINARY EXCRETION; VERY ELDERLY; WEIGHT LIFTING; WEIGHT REDUCTION; WHITE COAT HYPERTENSION;

ADULT; AGING; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; CANADA; CARDIOVASCULAR DISEASES; EXERCISE; HEALTH EDUCATION; HUMANS; HYPERTENSION; RISK ASSESSMENT;

EID: 84876814906     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2013.01.005     Document Type: Article

References (38)

1. McAlister F.A., Wilkins K., Joffres M., et al. Changes in the rates of awareness, treatment and control of hypertension in Canada over the past two decades. CMAJ 2011, 183:1007-1013.
2. Kannel W.B. Blood pressure as a cardiovascular risk factor: prevention and treatment. JAMA 1996, 275:1571-1576.
3. Yusuf S., Hawken S., Ounpuu S., et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004, 364:937-952.
4. Robitaille C., Dai S., Waters C., et al. Diagnosed hypertension in Canada: incidence, prevalence and associated mortality. CMAJ 2012, 184:E49-E56.
5. Lurbe E., Cifkova R., Cruickshank J.K., et al. Management of high blood pressure in children and adolescents: recommendations of the European Society of Hypertension. J Hypertens 2009, 27:1719-1742.
6. Hackam D.G., Khan N.A., Hemmelgarn B.R., et al. The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2-therapy. Can J Cardiol 2010, 26:249-258.
7. Khan N.A., Hemmelgarn B., Herman R.J., et al. The 2008 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2-therapy. Can J Cardiol 2008, 24:465-475.
8. Khan N.A., Hemmelgarn B., Herman R.J., et al. The 2009 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2-therapy. Can J Cardiol 2009, 25:287-298.
9. Khan N.A., McAlister F.A., Campbell N.R.C., et al. The 2004 Canadian recommendations for the management of hypertension: part II - therapy. Can J Cardiol 2004, 20:41-54.
10. Khan N.A., McAlister F.A., Lewanczuk R.Z., et al. The 2005 Canadian Hypertension Education Program recommendations for the management of hypertension: part II - therapy. Can J Cardiol 2005, 21:657-672.
11. Khan N.A., McAlister F.A., Rabkin S.W., et al. The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: part II - therapy. Can J Cardiol 2006, 22:583-593.
12. Khan N.A., Hemmelgarn B.R., Padwal R., et al. The 2007 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2-therapy. Can J Cardiol 2007, 23:539-550.
13. Padwal R.J., Hemmelgarn B.R., Khan N.A., et al. The 2008 Canadian Hypertension Education Program recommendations for the management of hypertension: part 1-blood pressure measurement, diagnosis and assessment of risk. Can J Cardiol 2008, 24:455-463.
14. Padwal R.S., Hemmelgarn B.R., Khan N.A., et al. The 2009 Canadian Hypertension Education Program recommendations for the management of hypertension: part 1-blood pressure measurement, diagnosis and assessment of risk. Can J Cardiol 2009, 25:279-286.
15. Padwal R.S., Hemmelgarn B.R., McAlister F.A., et al. The 2007 Canadian Hypertension Education Program recommendations for the management of hypertension: part 1-blood pressure measurement, diagnosis, and assessment of risk. Can J Cardiol 2007, 23:529-538.
16. Quinn R.R., Hemmelgarn B.R., Padwal R.S., et al. The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part I - blood pressure measurement, diagnosis and assessment of risk. Can J Cardiol 2010, 26:241-248.
17. Rabi D.M., Daskalopoulou S.S., Padwal R.S., et al. The 2011 Canadian Hypertension Education Program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk, and therapy. Can J Cardiol 2011, 27:415-433.
18. Daskalopoulou S.S., Khan N.A., Quinn R.R., et al. The 2012 Canadian Hypertension Education Program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk, and therapy. Can J Cardiol 2012, 28:270-287.
19. Beckett N.S., Peters R., Fletcher A.E., et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med 2008, 358:1887-1898.
20. Hansson L., Zanchetti A., Carruthers S.G., et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 1998, 351:1755-1762.
21. Cornelissen V.A., Fagard R.H., Coeckelberghs E., Vanhees L. Impact of resistance training on blood pressure and other cardiovascular risk factors: a meta-analysis of randomized, controlled trials. Hypertension 2011, 58:950-958.
22. McAlister F.A. The Canadian Hypertension Education Program-a unique Canadian initiative. Can J Cardiol 2006, 22:559-564.
23. Brouwers M.C., Kho M.E., Browman G.P., et al. AGREE II: advancing guideline development, reporting and evaluation in health care. CMAJ 2010, 182:E839-E842.
24. Sacks F.M., Svetkey L.P., Vollmer W.M., et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med 2001, 344:3-10.
25. Moore T.J., Vollmer W.M., Appel L.J., et al. Effect of dietary patterns on ambulatory blood pressure: results from the Dietary Approaches to Stop Hypertension (DASH) Trial. DASH Collaborative Research Group. Hypertension 1999, 34:472-477.
26. Karanja N.M., Obarzanek E., Lin P.H., et al. Descriptive characteristics of the dietary patterns used in the Dietary Approaches to Stop Hypertension Trial. DASH Collaborative Research Group. J Am Diet Assoc 1999, 99:S19-S27.
27. Appel L.J., Moore T.J., Obarzanek E., et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med 1997, 336:1117-1124.
28. Diao D., Wright J.M., Cundiff D.K., Gueyffier F. Pharmacotherapy for mild hypertension. Cochrane Database Syst Rev 2012, CD006742.
29. I. Reduction in mortality of persons with high blood pressure, including mild hypertension. Hypertension Detection and Follow-up Program Cooperative Group. JAMA 1979, 242:2562-2571. Five-year findings of the hypertension detection and follow-up program.
30. Gueyffier F., Bulpitt C., Boissel J.P., et al. Antihypertensive drugs in very old people: a subgroup meta-analysis of randomised controlled trials. Lancet 1999, 353:793-796.
31. Anderson T.J., Grégoire J., Hegele R.A., et al. 2012 update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adult. Can J Cardiol 2013, 29:151-167.
32. Lip-Gregory Y.H., Felmeden D.C., Dwivedi G. Antiplatelet agents and anticoagulants for hypertension. Cochrane Database Syst Rev 2011, CD003186.
33. Messerli F.H., Mancia G., Conti C.R., et al. Dogma disputed: can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous?. Ann Intern Med 2006, 144:884-893.
34. Bangalore S., Messerli F.H., Wun C.C., et al. J-curve revisited: an analysis of blood pressure and cardiovascular events in the Treating to New Targets (TNT) Trial. Eur Heart J 2010, 31:2897-2908.
35. Bangalore S., Qin J., Sloan S., Murphy S.A., Cannon C.P. What is the optimal blood pressure in patients after acute coronary syndromes?. Circulation 2010, 122:2142-2151. PROVE IT-TIMI.
36. Dorresteijn J., Van der Graaf Y., Spiering W., Grobbee D.E., Bots M.L., Visseren F.L.J. Relation between blood pressure and vascular events and mortality in patients with manifest vascular disease. Hypertension 2012, 59:14-21.
37. Kannel W.B., Wilson P.W.F., Nam B.H., D'Agostino R.B., Li J. A likely explanation for the J-curve of blood pressure cardiovascular risk (abstract). Am J Cardiol 2004, 94:380-384.
38. Hasebe N., Kido S., Ido A., Kenjiro K. Reverse J-curve relation between diastolic blood pressure and severity of coronary artery lesion in hypertensive patients with angina pectoris. Hypertens Res 2002, 25:381-387.